1. Home
  2. STVN vs CAE Comparison

STVN vs CAE Comparison

Compare STVN & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CAE
  • Stock Information
  • Founded
  • STVN 1949
  • CAE 1947
  • Country
  • STVN Italy
  • CAE Canada
  • Employees
  • STVN N/A
  • CAE N/A
  • Industry
  • STVN Containers/Packaging
  • CAE
  • Sector
  • STVN Consumer Discretionary
  • CAE
  • Exchange
  • STVN Nasdaq
  • CAE Nasdaq
  • Market Cap
  • STVN 6.3B
  • CAE 5.7B
  • IPO Year
  • STVN 2021
  • CAE N/A
  • Fundamental
  • Price
  • STVN $21.30
  • CAE $17.60
  • Analyst Decision
  • STVN Buy
  • CAE Buy
  • Analyst Count
  • STVN 5
  • CAE 3
  • Target Price
  • STVN $30.60
  • CAE $27.33
  • AVG Volume (30 Days)
  • STVN 386.4K
  • CAE 555.9K
  • Earning Date
  • STVN 10-29-2024
  • CAE 08-13-2024
  • Dividend Yield
  • STVN 0.27%
  • CAE N/A
  • EPS Growth
  • STVN N/A
  • CAE N/A
  • EPS
  • STVN 0.49
  • CAE N/A
  • Revenue
  • STVN $1,165,359,477.00
  • CAE $3,173,419,063.00
  • Revenue This Year
  • STVN $2.82
  • CAE $8.15
  • Revenue Next Year
  • STVN $9.77
  • CAE $5.85
  • P/E Ratio
  • STVN $43.54
  • CAE N/A
  • Revenue Growth
  • STVN 5.53
  • CAE 6.21
  • 52 Week Low
  • STVN $16.56
  • CAE $15.95
  • 52 Week High
  • STVN $35.56
  • CAE $25.04
  • Technical
  • Relative Strength Index (RSI)
  • STVN 57.54
  • CAE 48.27
  • Support Level
  • STVN $20.68
  • CAE $17.39
  • Resistance Level
  • STVN $23.20
  • CAE $18.03
  • Average True Range (ATR)
  • STVN 1.19
  • CAE 0.35
  • MACD
  • STVN 0.20
  • CAE 0.05
  • Stochastic Oscillator
  • STVN 60.74
  • CAE 34.21

About STVN Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: